13th ASM Conference on Candida and Candidiasis

第 13 届 ASM 念珠菌和念珠菌病会议

• 批准号: 9053214
• 负责人: Theodore C. White
• 金额: $ 0.8万
• 依托单位: AMERICAN SOCIETY FOR MICROBIOLOGY
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-02-15 至 2017-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9053214
• 关键词: AIDS/HIV problem; Achievement; Acquired Immunodeficiency Syndrome; Address; Affect; Agreement; American; Antifungal Agents; Area; Azoles; Biological; Candida; Candida albicans; Candida glabrata; Candidiasis; Case Study; Cell Communication; Chemotherapy-Oncologic Procedure; Clinical; Collaborations; Communicable Diseases; Communities; Community Developments; Development; Diagnosis; Disease; Disseminated candidiasis; Drug Interactions; Drug resistance; Educational workshop; Elevator; Epidemiology; Esophageal; Failure; Feedback; Filler; Financial Support; Frequencies; Funding; Fungal Drug Resistance; Genes; Genomics; Goals; Growth; Guidelines; Healthcare; Host Defense; Human; Imagination; Immune; Immune response; Immunocompetent; Immunocompromised Host; Immunology; Individual; Infection; International; Lead; Life; Medical; Metabolic; Microbial Biofilms; Microbiology; Minority; Modeling; Molecular; Names; Neonatal Intensive Care Units; Oral candidiasis; Oropharyngeal; Participant; Partner in relationship; Pathogenicity; Patients; Premature Infant; Prophylactic treatment; Proteomics; Publications; Recording of previous events; Research; Research Personnel; Resources; Role; San Francisco; Scientist; Series; Signal Transduction; Societies; Staging; Surveys; System; Systems Biology; Techniques; Technology; The science of Mycology; Therapeutic; Time; Training; Woman; abstracting; base; candidemia; career; flexibility; fungus; genome annotation; genome sequencing; in vivo; interest; meetings; mutant; new technology; pathogen; posters; prevent; programs; public health relevance; resistance mechanism; response; screening; success; symposium; tool; transcriptomics; vaginal candidiasis

 DESCRIPTION (provided by the applicant): Candida is the major fungal pathogen of humans, causing diseases that range from oral and vaginal candidiasis to life-threatening candidemia and invasive disease. The Candida research community focuses on a broad spectrum of subjects that relate to epidemiology, drug resistance, infection, host response, and therapeutics. The biennial Candida and Candidiasis Conference is the premier forum for presentation of cutting-edge advances and the latest perspectives in these diverse areas. Funds are requested for partial support for the 13th Conference on Candida and Candidiasis, to be held April 13 - 17, 2016, in Seattle, WA. The conference is sponsored in part by the American Society for Microbiology, which provides both management expertise and financial support. The Program is based upon past conferences, which reliably draw approximately 400 U.S. and International scientists, and have been met with enthusiastic support in participant surveys. The Program includes 17 sessions, with 5 or 6 speakers in each section. At least 68 of the talks will be selected based on submitted abstracts. Chairs for each session have been selected for their expertise in the subject area. This arrangement provides flexibility to present cutting-edge advances and to enlist a diverse spectrum of emerging and established speakers. Parallel sessions will address infection models, metabolic adaptation, fungal drug interactions and new technologies while encouraging productive interaction and discussion. "Elevator talks" will allow junior scientists to summarize their poster in a few minutes on stage. Three afternoon poster sessions will allow discussion of the 250-350 posters. Clinical talks about the epidemiology, diagnosis, and treatment of candidiasis will be incorporated into sessions that focus on key aspects of Candida infections, including environmental signaling, antifungal agents and resistance, and immune recognition. In a separate session on Candida case reports, clinicians will inform basic scientists about the challenges of diagnosing and treating different types of infection. We are confident that we will achieve our meeting goals - to present the latest advances in the field, to spotlight achievements of junior scientists (especially women and minorities), to promote synergistic and interdisciplinary interactions, and to provide a venue for community-wide discussion.

 描述（由申请人提供）：念珠菌是人类的主要真菌病原体，其疾病范围从口腔和阴道念珠菌病到危及生命的念珠菌血症和侵袭性疾病。念珠菌研究界专注于与流行病学相关的广泛主题，两年一度的念珠菌和念珠菌病会议是介绍这些不同领域的前沿进展和最新观点的首要论坛。请求为将于 2016 年 4 月 13 日至 17 日在华盛顿州西雅图举行的第 13 届念珠菌和念珠菌病会议提供部分支持。该会议由美国微生物学会部分赞助，该会议提供管理专业知识和财务支持。该计划以过去的会议为基础，可靠地吸引了大约 400 名美国和国际科学家，并在参与者调查中得到了热情支持。该计划包括 17 场会议，其中 5 场。每个部分至少有 68 名演讲者，每场会议的主席均根据其在该主题领域的专业知识进行选择。不同领域的新兴和成熟演讲者将讨论感染模型、代谢适应、真菌药物相互作用和新技术，同时鼓励富有成效的互动和讨论，让初级科学家在几分钟内总结他们的海报。三个下午的海报会议将讨论关于念珠菌病的流行病学、诊断和治疗的 250-350 张海报将被纳入关注念珠菌感染关键方面的会议中，包括环境信号、抗真菌药物和耐药性以及免疫识别。念珠菌病例报告，新人将向基础科学家介绍诊断和治疗不同类型感染的挑战，我们相信我们将实现我们的会议目标 - 展示该领域的最新进展，突出青年人的成就。科学家（特别是女性和少数族裔），促进协同和跨学科互动，并为全社区讨论提供场所。